After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Arvinas Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Arvinas Inc is $841.34M. A total of 0.92 million shares were traded on the day, compared to an average of 2.42M shares.
In the most recent transaction, Loomis David K sold 230 shares of ARVN for 9.89 per share on Nov 07 ’25. After the transaction, the Chief Accounting Officer now owns 31,697 company shares. In a previous transaction on Sep 22 ’25, Morrison Briggs bought 30,000 shares at 7.57 per share. ARVN shares that Director owns now total 76,021.
Among the insiders who sold shares, Saik Andrew disposed of 5,700 shares on Jun 24 ’25 at a per-share price of $7.61. This resulted in the Chief Financial Officer holding 164,401 shares of ARVN after the transaction. In another insider transaction, Andrew Saik bought 5,927 shares at $7.35 per share on Jun 24 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ARVN has a high of $26.78 and a low of $5.90.
As of this writing, ARVN has an earnings estimate of -$0.56 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of $0.02 per share and a lower estimate of -$1.05. The company reported an EPS of -$0.63 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ARVN’s latest balance sheet shows that the firm has $1.50B in Cash & Short Term Investments as of fiscal 2021. There were $5.00M in debt and $261.70M in liabilities at the time. Its Book Value Per Share was $7.97, while its Total Shareholder’s Equity was $781.70M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARVN is Buy with a score of 3.80.
